TheraTest Laboratories, Inc. was founded in 1988 by a group of clinical rheumatologists and laboratory investigators from the University of Illinois at Chicago. The company’s core mission is to develop accurate, sensitive, and reproducible methods for detecting and measuring autoantibodies, primarily through innovative ELISA-based technology. TheraTest provides specialist diagnostic products to clinicians and laboratory professionals worldwide, focusing on improving patient outcomes and enhancing practice revenue through in-practice lab implementations.
Notable affiliated individuals include its founders, who are eminent clinical rheumatologists and laboratory investigators. TheraTest has achieved significant milestones in autoimmune diagnostics, establishing itself as a leader in the field. The company’s impact is evident in its widespread adoption of ELISA-based technology, which has revolutionized the detection and measurement of autoantibodies, ultimately contributing to better patient care and more efficient clinical practices globally.